🟠 Moderate Evidence
Minerals are essential cofactors in brain function, yet remain underemphasized in clinical discussions of neurological health. Chromium, copper, iodine, iron, and lithium each regulate distinct mechanisms of neurotransmission, neuroplasticity, and cellular defense—meaning that even mild deficiencies can measurably alter mood, cognition, and mental resilience. Understanding these micronutrient roles offers clinicians and public health authorities a data-driven framework for identifying at-risk populations and optimizing neurological outcomes.
Key takeaways
- Iodine deficiency remains the leading preventable cause of cognitive impairment worldwide, particularly during pregnancy and early childhood
- Iron insufficiency impairs dopamine and serotonin synthesis, contributing to fatigue, poor concentration, and movement disorders
- Copper and zinc balance is critical for synaptic signaling; either excess or deficiency disrupts neurotransmitter regulation
- Lithium enhances neuroplasticity through BDNF stimulation and is an FDA-approved mood stabilizer with robust clinical evidence
- Chromium influences insulin sensitivity in the brain and serotonin receptor function, relevant to mood and appetite regulation
Global Burden of Micronutrient Deficiencies Affecting Brain Function
Estimated number of people affected by key mineral deficiencies impacting cognition and neurological health
Source: World Health Organization Global Health Observatory; CDC Micronutrient Deficiency Database | Georgian Medical Journal News
Iodine and Cognitive Development: From Fetal Programming to Lifelong Impact
Iodine deficiency remains the leading preventable cause of cognitive impairment worldwide, according to assessments by the World Health Organization (WHO). The mineral is essential for thyroid hormone synthesis, which controls brain energy metabolism and neuronal development. When iodine intake is inadequate during pregnancy and infancy—critical windows for brain development—cognitive deficits can be profound and permanent.
Approximately 2 billion people are estimated to have insufficient iodine intake, according to WHO micronutrient fact sheets. In affected regions, children show measurable reductions in IQ and increased rates of cretinism (severe intellectual disability combined with growth stunting). Salt iodization programs, now implemented in more than 130 countries according to UNICEF reports, have successfully prevented millions of cases of cognitive impairment, though access remains inequitable in parts of sub-Saharan Africa and South Asia.
Iron, Dopamine, and the Neurotransmitter Axis
Iron is an essential cofactor in the synthesis of dopamine and serotonin, the neurotransmitters central to motivation, mood, and motor control. The mineral is also required for myelination—the insulation of nerve fibers—which enables rapid neural signal propagation. Research on iron’s role in cognition shows that iron-deficient individuals often report fatigue, poor concentration, and impaired executive function, with symptoms often reversing once ferritin levels are restored.
Iron deficiency anemia affects approximately 1.4 billion people globally, according to WHO estimates. In developing countries, where iron deficiency is endemic, children show delayed developmental milestones and reduced school performance. Adult women and older adults are at particular risk, and screening for iron status may be warranted in patients presenting with cognitive complaints or mood disturbance. This has direct implications for clinical diagnosis and treatment protocols.
Copper–Zinc Balance and Synaptic Function
Copper and zinc work in concert to regulate synaptic signaling and maintain the excitatory–inhibitory balance in the brain. Both minerals are required for GABA receptor function and the activity of Cu/Zn-superoxide dismutase, a critical antioxidant enzyme. An imbalance in the copper-to-zinc ratio—whether elevated copper or zinc depletion—is associated with anxiety, learning difficulties, and altered neurotransmission, according to neurochemical studies.
Copper excess, sometimes seen in individuals consuming water from corroded copper pipes or copper supplementation, can increase oxidative stress in the brain. Conversely, zinc deficiency—affecting an estimated 1 billion people globally per WHO micronutrient assessments—impairs immune function, wound healing, and neuronal plasticity. Clinicians should maintain awareness of both deficiency and toxicity risk, particularly in patients with high dietary copper or those using chelation therapy.
Lithium, Neuroplasticity, and Mood Stabilization
Lithium is unique among minerals in that it has strong clinical evidence as a psychiatric medication. The element promotes neuroplasticity by stimulating the release of brain-derived neurotrophic factor (BDNF), a protein essential for neuronal survival, growth, and synaptic plasticity. Clinical trials and meta-analyses consistently demonstrate lithium’s efficacy in reducing relapse rates in bipolar disorder and augmenting antidepressant response in major depression.
Lithium therapy, approved by the U.S. Food and Drug Administration (FDA) and widely used in psychiatric practice, requires careful monitoring due to a narrow therapeutic window. Blood levels must be maintained between 0.6 and 1.2 mEq/L to achieve efficacy while avoiding toxicity. Research also indicates potential neuroprotective effects, with some studies suggesting lithium may slow cognitive decline in neurodegenerative conditions, though evidence remains preliminary. Access to lithium and appropriate monitoring remains a critical health equity issue in resource-limited settings.
Iodine deficiency alone affects 2 billion people globally and remains the leading preventable cause of cognitive impairment, with pregnant women and young children at highest risk of permanent neurological damage.
— World Health Organization, Global Health Observatory, 2024
Chromium, Insulin Sensitivity, and Mood Regulation
Chromium enhances insulin sensitivity in the brain by supporting GLUT-4 glucose transporters, which facilitate glucose uptake into neurons. The mineral also modulates serotonin receptor sensitivity, influencing appetite control and mood stability. Research on chromium supplementation has shown promise in treating atypical depression—characterized by carbohydrate craving, hypersomnia, and mood reactivity—particularly in individuals with insulin resistance.
While chromium is present in whole grains, brewer’s yeast, and meat, processing and refining reduce dietary chromium content significantly. Chromium picolinate, the most bioavailable form, has been investigated in clinical trials for mood and metabolic effects, though evidence remains modest. Further research is needed to establish optimal dosing and identify populations most likely to benefit from supplementation.
What this means
Frequently asked questions
Can mineral deficiencies cause depression?
Yes. Iron deficiency impairs dopamine synthesis, zinc deficiency reduces GABA signaling, and iodine deficiency slows thyroid hormone metabolism—all of which contribute to mood disorders. Research published in peer-reviewed journals shows that correcting these deficiencies often improves depressive symptoms, particularly when combined with standard psychiatric treatment. A medical evaluation is essential to determine whether deficiency is contributing to mood symptoms.
Is it safe to take mineral supplements?
Some minerals have a narrow margin between therapeutic and toxic doses. Lithium, for example, requires blood level monitoring. Copper excess can increase oxidative stress, and iron overload increases cancer and cardiovascular risk. Supplementation should be based on documented deficiency confirmed by laboratory testing, and dosing should follow evidence-based guidelines. Always consult a healthcare provider before starting supplements.
Which populations are most at risk of mineral deficiency?
Pregnant and lactating women, young children, older adults, people with malabsorption disorders (celiac disease, inflammatory bowel disease), and those in regions with iodine-poor soil are at highest risk. Vegetarians and vegans may have lower iron and zinc intake. Targeted screening and public health interventions should prioritize these groups to prevent cognitive and neurological impairment.
The emerging evidence on minerals and brain function underscores a fundamental principle in medicine: micronutrient status directly impacts neurological and psychiatric health. As global awareness of mental health increases, integrating micronutrient assessment into routine clinical practice—and scaling public health interventions like salt iodization—offers a pragmatic, evidence-based pathway to reducing preventable cognitive impairment and improving mental health outcomes across populations.
Source: Evidence-based synthesis of micronutrient-brain function research from WHO, UNICEF, and peer-reviewed neuroscience literature. Original article: Minerals and the brain: how micronutrients shape neurological function.
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
